Validus (VR) Stock Rating Lowered by Keefe, Bruyette & Woods

Validus (NYSE:VR) was downgraded by investment analysts at Keefe, Bruyette & Woods from an “outperform” rating to a “market perform” rating in a research report issued on Monday, The Fly reports.

Other equities research analysts have also recently issued research reports about the stock. Bank of America raised shares of Validus from a “neutral” rating to a “buy” rating in a report on Monday, October 30th. TheStreet cut shares of Validus from a “b” rating to a “c+” rating in a report on Wednesday, October 11th. Barclays reduced their price objective on shares of Validus from $57.00 to $53.00 and set an “equal weight” rating for the company in a research note on Monday, October 16th. ValuEngine upgraded shares of Validus from a “sell” rating to a “hold” rating in a research note on Friday, October 20th. Finally, Zacks Investment Research upgraded shares of Validus from a “strong sell” rating to a “hold” rating in a research note on Thursday, October 5th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating and three have assigned a buy rating to the company’s stock. Validus presently has an average rating of “Hold” and a consensus price target of $54.33.

Validus (NYSE:VR) traded up $20.57 during trading hours on Monday, hitting $67.29. 30,805,862 shares of the company were exchanged, compared to its average volume of 2,779,072. The company has a debt-to-equity ratio of 0.52, a current ratio of 0.95 and a quick ratio of 0.95. The company has a market cap of $3,712.46, a PE ratio of -103.52, a PEG ratio of 1.26 and a beta of 0.67. Validus has a 52 week low of $41.15 and a 52 week high of $67.60.

Validus (NYSE:VR) last posted its quarterly earnings results on Thursday, October 26th. The insurance provider reported ($3.22) EPS for the quarter, topping analysts’ consensus estimates of ($3.30) by $0.08. The company had revenue of $407.00 million for the quarter, compared to analysts’ expectations of $453.04 million. Validus had a negative net margin of 1.38% and a negative return on equity of 0.49%. Validus’s revenue was up 24.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.02 EPS. sell-side analysts anticipate that Validus will post -0.3 EPS for the current year.

In other news, President Kean Driscoll sold 6,875 shares of the business’s stock in a transaction on Wednesday, November 15th. The shares were sold at an average price of $50.30, for a total transaction of $345,812.50. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO Lixin Zeng sold 26,136 shares of the business’s stock in a transaction on Wednesday, November 1st. The shares were sold at an average price of $52.10, for a total transaction of $1,361,685.60. Following the transaction, the chief executive officer now owns 57,855 shares of the company’s stock, valued at $3,014,245.50. The disclosure for this sale can be found here. Insiders sold a total of 46,761 shares of company stock valued at $2,346,461 over the last quarter. 2.33% of the stock is owned by company insiders.

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Vanguard Group Inc. grew its position in Validus by 1.8% in the second quarter. Vanguard Group Inc. now owns 6,302,341 shares of the insurance provider’s stock worth $327,534,000 after acquiring an additional 109,287 shares in the last quarter. State Treasurer State of Michigan grew its position in Validus by 11.4% in the third quarter. State Treasurer State of Michigan now owns 3,798,643 shares of the insurance provider’s stock worth $186,931,000 after acquiring an additional 390,000 shares in the last quarter. BlackRock Inc. grew its position in Validus by 11.2% in the second quarter. BlackRock Inc. now owns 3,597,480 shares of the insurance provider’s stock worth $186,963,000 after acquiring an additional 361,617 shares in the last quarter. Wells Fargo & Company MN grew its position in Validus by 3.2% in the third quarter. Wells Fargo & Company MN now owns 2,463,909 shares of the insurance provider’s stock worth $121,248,000 after acquiring an additional 76,636 shares in the last quarter. Finally, Diamond Hill Capital Management Inc. grew its position in Validus by 10.0% in the third quarter. Diamond Hill Capital Management Inc. now owns 1,960,885 shares of the insurance provider’s stock worth $96,495,000 after acquiring an additional 177,479 shares in the last quarter. Hedge funds and other institutional investors own 96.29% of the company’s stock.

TRADEMARK VIOLATION WARNING: “Validus (VR) Stock Rating Lowered by Keefe, Bruyette & Woods” was first published by American Banking News and is the sole property of of American Banking News. If you are viewing this story on another website, it was illegally copied and reposted in violation of United States & international trademark & copyright legislation. The original version of this story can be accessed at https://www.americanbankingnews.com/2018/01/22/validus-vr-stock-rating-lowered-by-keefe-bruyette-woods.html.

About Validus

Validus Holdings, Ltd. is a holding company. The Company operates through four segments: Validus Re, Talbot, Western World and AlphaCat. Validus Re is a Bermuda-based reinsurance segment focused treaty reinsurance. Validus Re concentrates on first-party property and other reinsurance risks. Talbot is a specialty insurance segment operating within the Lloyd’s insurance market through Syndicate 1183.

The Fly

Analyst Recommendations for Validus (NYSE:VR)

Receive News & Ratings for Validus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Validus and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply